Carregant...
Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
The development and licensing of a nonavalent human papillomavirus (HPV) vaccine has the potential to reduce morbidity and mortality from HPV-related cancers beyond that of first generation HPV vaccines. However, this benefit can only be realised if the offer of vaccination is accepted. Uptake of fi...
Guardat en:
| Publicat a: | Eur J Cancer |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Science Ltd
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4920641/ https://ncbi.nlm.nih.gov/pubmed/27235782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2016.04.014 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|